The main findings of our research are (1) a high serum AT1-AAs level was closely associated with PAD; (2) long-term exposure to AT1-AAs could induce vascular aging and EC senescence in vivo; (3) AT1-AAs-IgGs induced EC senescence in an AT1 receptor-dependent pathway. This evidence concerns the gene AGTR1 and peripheral arterial disease.